Search

everythinglearnresearchcommunity

for

Search:↓

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Tofacitinib may help treat severe hair loss, but more research is needed.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Laser hair removal is safe and effective for fair-skinned people with dark hair, and using eflornithine with laser treatments can improve results.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Early menarche may indicate higher risk of severe hirsutism in PCOS patients.

Vitamin A deficiency changes cattle hair structure, while pregnancy may improve it, suggesting hair can indicate cattle health.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

Dutasteride may become the top choice for treating hair loss.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

The document concludes that more research is needed to understand how PRP affects the ovaries and to standardize its use in treatment.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.